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Background: In an attempt to characterize the intracranial pressure-volume
compensatory reserve capacity, the correlation coefficient (R) between the ICP wave
amplitude (A) and the ICP (P) level (RAP) has been applied in the surveillance of
neurosurgical patients. However, as the ICP level may become altered by
electrostatic discharges, human factors, technical factors and technology issues
related to the ICP sensors, erroneous ICP scores may become revealed to the
physician, and also become incorporated into the calculated RAP index. To evaluate
the problem with regard to the RAP, we compared simultaneous RAP values from
two separate ICP signals in the same patient.
Materials and Methods: We retrieved our recordings in 20 patients with cerebral
bleeds wherein the ICP had been recorded simultaneously from two different
sensors. Sensor 1 was always a solid sensor while sensor 2 was a solid sensor
(Category A), a fluid sensor (Category B), an air-pouch sensor (Category C), or a fibre-
optic sensor (Category D). The simultaneous signals were analyzed with automatic
identification of the cardiac induced ICP waves, with subsequent determination and
comparison of the Pearson correlation coefficient between mean wave amplitude
(MWA) and mean ICP (RAP) for 40 6-s time windows every 4-min period.
Results: A total of 23,056 4-min RAP observations were compared. A difference in
RAP ≥0.4 between the two signals was seen in 4% of the observations in Category
A-, in 44% of observations in Category B -, in 20% of observations in Category C -,
and in 28% of observations in Category D patients, respectively. Moreover, the
combination of a RAP of <0.6 in one signal and ≥0.6 in the other was seen in >20%
of scores in 3/5 Category A -, in 3/5 Category B -, in 5/7 Category C - and 1/3
Category D patients.
Conclusions: Simultaneous monitoring of the ICP-derived index RAP from two
separate ICP sensors reveals marked differences in the index values. These differences
in RAP may be explained by erroneous scoring of the ICP level. This will hamper the
usefulness of RAP as a guide in the management of neurosurgical patients.© 2013 Eide and Sorteberg; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
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Monitoring of the intracranial pressure (ICP) remains a cornerstone in the intensive
care management of neurosurgical patients [1-3]. Besides scoring the level of ICP
(mean ICP), monitoring of the cardiac-induced ICP waves has lately received atten-
tion [4-6]. The management goal is then to keep the mean ICP <20-25 mmHg [1,7],
or the mean ICP wave amplitude (MWA) <5 mmHg [5]. In an attempt to characterize
the intracranial pressure-volume compensatory reserve capacity some authors have
in addition calculated ICP-derived indices [6,8,9]. An index measuring the correlation
coefficient (R) between the ICP wave amplitude (A) and the mean ICP (P) level
(referred to as RAP) has thus been applied in the surveillance of patient groups
such as those suffering from traumatic brain injury (TBI), cerebral bleeds or hydro-
cephalus [8,10-12]. With an upper normal threshold level of about + 0.6 [3,8,11-14]
a RAP approaching +1 has been considered as indicative of reduced compensatory
reserve capacity.
A crucial, though yet less recognized, aspect of monitoring the level of ICP is that it
may become altered by electrostatic discharges in the hospital environment [15], or
through human factors, technical factors and technology issues related to the ICP
sensors [16]. The consequence of these changes in baseline pressure is then erroneous
ICP revealed to the physician [16]. Using these erroneous ICP values when calculating
an index, e.g. the RAP, one could anticipate errors being incorporated into the index
as well. To see if this in fact occurs, we designed a study wherein simultaneous RAP
values derived from two separate ICP sensors in the same patient were compared.
The concept of simultaneous measurements from two separate sensors in the same
patient was used because erroneous ICP values usually do not become introduced at
the same time in both sensors [16]. To this end, and with special emphasize on
differences in RAP between the two signals, ICP scores from 20 patients with cerebral




The ICP recordings were retrieved from patients managed for aneurysmal subarach-
noid haemorrhage (SAH) and/or intra-cerebral haemorrhage (ICH) at the Department
of Neurosurgery, Oslo University Hospital – Rikshospitalet during the time period
2002–2011. All patients wherein management included simultaneous monitoring from
two separate ICP sensors were included.
The Regional Committee for Medical and Health Research Ethics (REK) of Health
Region South-East, Norway approved the study as a quality study (2010/1328). The
study was also approved by the Oslo University Hospital – Rikshospitalet as a quality
study (2010/16315).
ICP monitoring and analysis
The setup for the simultaneous ICP monitoring was as follows: Sensor 1 was always a
solid (strain-gauge) sensor (Codman Microsensor, Codman MicroSensor, Johnson and
Johnson, Raynham, Massachusetts, USA), while Sensor 2 was either (a) another solid
sensor (Codman Microsensor, Codman MicroSensor, Johnson and Johnson, Raynham,
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to an external ventricular drain (Truwave PX-600F Pressure Monitoring Set, Edwards
Life sciences LLC, Irvine, CA, USA; Category B), (c) an air-pouch sensor (Spiegelberg
intraparenchymal probe 3PN, Spiegelberg KG, Hamburg, GE; Category C), or a fibre-
optic sensor (Camino OLM ICP sensor, Camino Laboratories, San Diego, CA; Category
D). Both ICP sensors were implanted at the same time.
The ICP sensors were introduced to the intracranial compartment either via a small
burr hole and a minimal opening in the dura or via the craniotomy used for aneurysm
clipping/hematoma evacuation. The solid sensor was placed within the brain paren-
chyma, and connected via cable to the ICP Express (Codman ICP Express, Johnson and
Johnson, Raynham, Massachusetts, USA). The fluid sensor was connected outside the
patient to an external ventricular drain (EVD) that had been placed in the ventricular
fluid, while the air-pouch sensor was placed in the ventricular fluid, and connected to a
Spiegelberg ICP Monitor (Spiegelberg KG, Hamburg, Ge). The fibre-optic sensor was
placed within the brain parenchyma, and connected via cable to the MPM-1 Camino
monitor (Camino Laboratories, San Diego, CA). The ICP signals from all sensors were
passed to a vital signs Siemens 9000 XL Series Monitor (Siemens Medical Systems Inc.,
Danvers, MA, USA). By means of the Siemens Infinity Gateway Software (Siemens
Medical Systems Inc., Danvers, MA, USA), the continuous ICP signals were transferred
online via the hospital network to a computer server and stored as raw data files
(sampling rate 100 Hz).
The analysis of the continuous ICP waveforms was done using a previously published
method for automatic identification of cardiac induced ICP waves [17]. The method
has been implemented in the software (Sensometrics Software, dPCom As, Oslo,
Norway). Each single ICP wave becomes identified by its beginning and ending diastolic
minimum pressure, and its systolic maximum pressure, and various single ICP wave
parameters are determined, such as the pressure difference between the beginning
diastolic and systolic pressures (dP). For 6-s time windows containing a minimum of 4
cardiac induced ICP waves, the mean ICP and the mean ICP wave amplitude (MWA)
were determined.
The correlation coefficient (R) between the ICP wave amplitude (A) and ICP (P) level
(RAP) was determined during consecutive 4-min time periods [8,14]. Thus, the RAP
represents the Pearson correlation coefficient between the MWA and the mean ICP in
40 6-s time window periods. Since we compared RAP of two simultaneous ICP signals,
the RAP of Sensors 1 and 2 were derived from simultaneous 6-s time windows
(Figure 1a-b). For every consecutive 4-min period the software hence determined the
Pearson correlation coefficient (RAP) values of the two ICP signals (Figure 1c-d). The
RAP scores could then be trended as shown in Figure 2.
The Pearson correlation coefficient is a measure of the strength of a relationship be-
tween two variables and may range from −1 to +1. A negative correlation coefficient
occurs when one variable changes in the opposite direction of the other; whereas a
positive correlation coefficient indicates that both variables change in the same direc-
tion (Figure 1c-d). The closer the correlation coefficient is to +1, the stronger is the
relationship between the two variables.
Based on previous findings, the assumptions for using the Pearson correlation coeffi-
cient were fulfilled: both the ICP and the MWA are continuous and independent
Figure 1 (See legend on next page.)
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(See figure on previous page.)
Figure 1 Illustration of the method of determining the RAP in patient 1. Following automatic
identification of the cardiac induced single intracranial pressure (ICP) waves, the mean ICP and mean wave
amplitude (MWA) are determined for every 6-s time window. Trend plots of mean ICP and MWA
determined during the same 6-s time windows are shown for Signals 1 (a) and 2 (b) over a 12 min period
(representing three 4-min periods, and 120 6-s time windows). For Signal 1 (a) the average (±standard
deviation) of mean ICP was 6.1±0.7 mmHg and of MWA 4.7±0.3 mmHg; while for Signal 2 (b) mean ICP 3.6
±0.7 mmHg and MWA 4.8+0.3 mmHg (mean difference of ICP −2.4±0.2 mmHg; mean difference of MWA
0.09±0.17 mmHg). RAP is determined as the Pearson correlation coefficient between mean ICP and MWA
during subsequent 4 min periods (representing 40 6-s time windows). For the 20 patients in this study, we
compared the RAP values during the same 4-min periods for Signals 1 and 2. For the 4-min period shown
here, RAP was 0.54 for Signal 1 (c) while 0.79 for Signal 2 (d). The difference in RAP during this 4 min period
was related to the difference in mean ICP [mean ICP: 5.9±0.7 mmHg (Signal 1) vs. 3.5±0.8 mmHg (Signal 2)],
while the difference in MWA was marginal [MWA: 4.6±0.3 mmHg (Signal 1) vs. 4.7±0.3 mmHg (Signal 2)].
This is further illustrated in a Bland-Altman [33] plot showing less agreement between mean ICP (e; mean
difference = 2.43 mmHg; mean + 2SD = 2.76 mmHg; mean – 2SD = 2.10 mmHg), while higher agreement
between MWA of Signals 1 and 2 (f; mean difference = −0.09 mmHg; mean + 2SD = 0.41 mmHg; mean –
2SD = −0.59 mmHg).
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coefficient between these two observations reflects a linear relationship.
Results
Patient recordings
Table 1 gives information with regard to demography, type of cerebral bleed, and the
ICP sensor types and locations for the 20 patients.
Simultaneous RAPs of Signal 1 and Signal 2
Figure 1 illustrates how RAP may differ between Signals 1 and 2 due to differences in
mean ICP level while MWA being close to identical.
Simultaneous RAP scores from Signal 1 and Signal 2 are presented in Table 2. Table 2,
left shows the number of 4-min RAP scores in each patient. For all 20 patients
combined, a total of 23,056 4-min RAP scores were analyzed. Table 2, middle presents
the RAP scores (mean and ± std) for each patient. Values ≥0.6 (upper limit of normal-
ity) are highlighted. Table 2, right shows differences in RAP between Signal 1 and Sig-
nal 2 exceeding 0.2, 0.4 and 0.6, respectively. A difference in RAP ≥0.4 between the two
signals was seen in 4% of the observations in Category A-, in 44% of observations in
Category B -, in 20% of observations in Category C -, and in 28% of observations in
Category D patients, respectively D (Table 2).
Figure 2 illustrates how the RAP could differ between Signals 1 and 2. The figure
shows short trends of RAP signals in Category A- (Figure 2a), B- (Figure 2b), C-
(Figure 2c) and D patients (Figure 2d), respectively. This aspect is further illustrated in
Figure 3, showing histograms of the differences in RAP between the two signals for all
scores. Examples are presented of patients in Category A (Figure 3a), B (Figure 3b), C
(Figure 3c) and D (Figure 3d), respectively.
Table 3 presents the portion of 4-min observations wherein RAP was <0.6 in both
signal (left), ≥0.6 in both signals (middle) and <0.6 in one signal and ≥0.6 in the other
(right). The combination of a RAP of <0.6 in one signal and ≥0.6 in the other was seen
in >20% of scores in 3/5 Category A patients, in 3/5 Category B patients, in 5/7 Cat-
egory C patients and 1/3 Category D patients, respectively.
Figure 2 Trend plots of RAP, mean ICP and MWA of Signals 1 and 2 in patients 1 and 20. For patient
1 the trend plots of (a) RAP determined during consecutive 4-min periods for Signal 1 and 2 show marked
differences (average of RAPSignal 1 0.22; average of RAPSignal 2 0.63), accompanied with marked differences in (b)
mean ICP (average of mean ICPSignal 1 6.6 mmHg; average of mean ICPSignal 2 2.2 mmHg) while minor
differences in (c) MWA (average of MWASignal 1 4.0 mmHg; average of MWASignal 2 3.9 mmHg). Similarly, for
patient 20 the trend plots of (d) RAP revealed marked differences (average of RAPSignal 1 0.72; average of
RAPSignal 2 0.29), and markedly different (e) mean ICP (average of mean ICPSignal 1 3.5 mmHg; average of mean
ICPSignal 2 13.2 mmHg) despite similar (f) MWA (average of MWASignal 1 2.4 mmHg; average of MWASignal 2 2.8
mmHg). The horizontal lines at RAP 0.6 illustrate a commonly used upper normal threshold for RAP.
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The main finding of the present study was that simultaneous monitoring of the ICP-
derived index RAP from two separate ICP sensors in the same patient revealed marked
differences in index values. In a setting where erroneous ICP values are introduced at
separate points of time in the two sensors, this finding could be anticipated. To our
knowledge, this is further the first study wherein RAP values from simultaneous ICP
signals are compared.
Table 1 Information about demography, type of bleed and ICP sensor type and location
in 20 patients with cerebral bleeds
PatID Age Gender Type of bleed Sensor type Sensor location
Signal 1 Signal 2 Signal 1 Signal 2
Category A
1 66 M SAH (ACOM) Solid Solid Left frontal lobe Right frontal lobe
2 76 M ICH
(right parieto-occipital)
“ “ Left frontal lobe Left occipital lobe
3 39 F SAH (ACOM) “ “ Right frontal lobe Right occipital lobe
4 72 F SAH (left MCA) “ “ Left frontal lobe Left frontal
ventricular horn
5 59 F SAH (left MCA) “ “ Right frontal lobe Right frontal
ventricular horn
Category B
6 56 M SAH (BA) Solid Fluid Right frontal lobe Right frontal
ventricular horn
7 48 M SAH (left MCA) “ “ Right frontal lobe Right frontal
ventricular horn
8 60 M SAH (ACOM) “ “ Right frontal lobe Right frontal
ventricular horn
9 50 F SAH (right VA) “ “ Right frontal lobe Right frontal
ventricular horn
10 55 F SAH (ACOM) “ “ Left frontal lobe Left frontal
ventricular horn
Category C
11 66 M ICH (right frontal)/IVH Solid Air-pouch Right frontal lobe Right frontal
ventricular horn
12 56 F SAH (right MCA) “ “ Right frontal lobe Right frontal
ventricular horn
13 60 F SAH (BA/left ICA) “ “ Right frontal lobe Right frontal
ventricular horn
14 54 M SAH (left PCOM) “ “ Right frontal lobe Right frontal
ventricular horn
15 67 M SAH (right PCOM) “ “ Left frontal lobe Left frontal
ventricular horn
16 71 M ICH (cerebellum) “ “ Right frontal lobe Right frontal
ventricular horn
17 82 F ICH (cerebellum) “ “ Right frontal lobe Right frontal
ventricular horn
Category D
18 60 F SAH (right ICA) Solid Fibre-optic Right frontal lobe Right frontal lobe
19 71 M SAH (ACOM) “ “ Right frontal lobe Right frontal lobe
20 52 F SAH (left PCOM) “ “ Right frontal lobe Right frontal lobe
ACOM: anterior communicating artery; BA: basilar artery; ICA: internal carotid artery; ICH: Intra-cerebral haemorrhage; IVH:
intra-ventricular haematoma; MCA: middle cerebral artery; PCOM: posterior communicating artery; SAH: Subarachnoid
haemorrhage; VA: vertebral artery.
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Table 2 Comparison of RAP between Signals 1 and 2
PatID N (4-min RAP observations) RAP (average + std) Differences in RAP between Signals 1
and 2 (N, %)
Signal 1 Signal 2 0.2 0.4 0.6
Category A
1 685 0.45±0.4 0.42±0.39 315 (46%) 162 (24%) 45 (7%)
2 1,040 0.37±0.22 0.36±0.22 105 (10%) 6 (1%) 1
3 414 0.83±0.17 0.78±0.21 52 (13%) 18 (4%) 7 (2%)
4 604 0.58±0.29 0.65±0.28 115 (19%) 23 (4%) 8 (1%)
5 1,065 0.57±0.38 0.59±0.36 419 (39%) 206 (19%) 78 (7%)
Category B
6 211 0.55±0.39 −0.74±0.20 207 (98%) 201 (95%) 190 (90%)
7 1,499 0.56±0.35 0.11±0.58 1,060 (71%) 838 (56%) 673 (45%)
8 274 0.67±0.37 0.28±0.67 140 (51%) 95 (35%) 70 (26%)
9 191 0.09±0.43 0.13±0.43 130 (68%) 84 (44%) 44 (23%)
10 302 0.88±0.13 0.86±0.14 61 (20%) 17 (6%) 1
Category C
11 1,834 0.62±0.27 0.80±0.17 844 (46%) 347 (19%) 129 (7%)
12 4.777 0.15±0.29 0.16±0.28 2,661 (56%) 1,135 (24%) 427 (9%)
13 1,861 0.33±0.35 0.35±0.32 922 (50%) 345 (19%) 103 (6%)
14 2,361 0.34±0.31 0.30±0.35 1,259 (53%) 573 (24%) 234 (10%)
15 2,022 0.50±2.9 0.38±0.32 923 (46%) 500 (25%) 318 (16%)
16 15 0.31±0.34 0.45±0.40 4 (26.7%) 3 (20%) 2 (13%)
17 764 0.71±0.27 0.69±0.34 197 (26%) 99 (13%) 62 (8%)
Category D
18 1,841 0.66±0.28 0.61±0.31 354 (19%) 114 (6%) 35 (2%)
19 578 0.04±0.36 0.06±0.34 319 (55%) 162 (28%) 87 (15%)
20 718 0.65±0.35 0.48±0.43 339 (47%) 215 (30%) 135 (19%)
RAP: Relationship Amplitude – Pressure.
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The rational for introducing ICP-derived indices have been to enhance the diagnostic
information of ICP monitoring [3,8]. The most commonly used such index, the correl-
ation coefficient (R) between the ICP wave amplitude (A) and ICP (P) level (RAP),
which is considered to be an indicator of the intracranial pressure volume compensa-
tory reserve capacity [3,6,10,14]. The RAP should thus be of particular value in the sur-
veillance of patients with TBI [8,12,14,18], cerebral bleeds and hydrocephalus
[10,11,13]. With an upper normal threshold level of about + 0.6 [3,8,11-14], however,
the clinical usefulness of this index remains to be determined [4,19,20]. One reason for
this could be the erroneous ICP values being incorporated into the index value.
The RAP was originally determined from amplitudes computed using the frequency
domain method [8,14]. In contrast, the MWA was presently determined using the time
domain method [17]. Although the two methods are not equivalent with regard to
computation of ICP wave amplitudes [21], how amplitudes are computed should not
affect the results since amplitudes are relative values not being affected by baseline
pressure. Also, the concept of RAP being an indicator of intracranial pressure reserve
capacity should not be affected by the method of computing amplitudes.
Figure 3 Histograms show frequency of differences in RAP between identical Signals 1 and 2 in patients
1 and 20. Histograms of differences in RAP between identical 4-min periods of Signal 1 and 2 are shown for
PatID’s 1 [a; mean difference (+std) = 0.02±0.36, n = 685], and 20 [a; mean difference (+std) = −0.17±0.45; n = 718].
The histograms illustrate that despite minor mean difference in RAP between Signals 1 and 2 of all 4-min
periods, the frequency of major negative and positive differences in RAP can be extensive.
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We have previously observed markedly different mean ICP levels from two simultan-
eous ICP measurements [16,22,23]. As we recently reported in the very same ICP
recordings as presented here, the differences in mean ICP occurred despite of close to
identical MWAs (Patients 1–17; ref [16]; Patients 18–20, ref [22]). The fluctuations in
the mean ICP were caused by spontaneous shifts and drifts of the ICP baseline pres-
sure. As the ICP is a pressure value relative to the atmospheric pressure (representing
the baseline or reference pressure), any change in baseline pressure obviously will affect
the ICP level being scored.
There are three major factors related to hospital environment that may affect the ICP
baseline pressure: Human factors, technical issues and technology issues. The most im-
portant human factor is erroneous zeroing of the ICP sensor, and mal-positioning of
the sensor/catheter. Technical issues include sensor damage that may occur dur-
ing implantation or at any point during monitoring and sensitivity to electrostatic
discharges (ESD’s) [15]. Moreover, when using a fluid system, loss of fluid con-
tinuity due to air bubbles and/or partial/total occlusion of the fluid catheter by
blood cloths or brain tissue may cause erroneous pressure reproduction. Techno-
logy issues relate to the properties of the ICP sensor itself. For the ICP sensors
used here, we have shown how the transfer function varies between solid and
fluid/air pouch sensors, making the air pouch sensor less useful for reproduction
of pressure waveforms [16]. All factors mentioned above may thus contribute to
the observed differences in RAP.
Comparison of RAP scores from two simultaneous ICP signals
In a significant proportion of our observations, there were marked differences in RAP
between Sensors 1 and 2 (Table 2). A difference in RAP ≥0.4 between the two signals
was hence seen in >20% of the observations in more than half of the patients. It might
be questioned whether these differences are of clinical importance. To explore this
Table 3 Proportion of 4-min observations with RAP <0.6 in both signals (left), RAP ≥0.6






RAPSIGNAL 1≥0.6/RAPSIGNAL 2<0.6 or
RAPSIGNAL 1<0.6/RAPSIGNAL 2≥0.6
Category A
1 308 (45%) 233 (34%) 144 (21%)
2 842 (81%) 115 (11%) 83 (8%)
3 21 (5%) 339 (82%) 54 (13%)
4 176 (29%) 319 (53%) 109 (18%)
5 319 (30%) 501 (47%) 245 (23%)
Category B
6 95 (45%) 0 116 (55%)
7 536 (36%) 272 (18%) 691 (46%)
8 65 (24%) 118 (43%) 91 (33%)
9 156 (82%) 4 (2%) 31 (16%)
10 5 (2%) 270 (89%) 27 (9%)
Category C
11 140 (8%) 1066 (58%) 628 (34%)
12 4,306 (90%) 34 (1%) 437 (9%)
13 1,176 (63%) 266 (14%) 419 (23%)
14 1,542 (65%) 318 (14%) 501 (21%)
15 985 (49%) 390 (19%) 647 (32%)
16 10 (67%) 3 (20%) 2 (13%)
17 116 (15%) 494 (65%) 154 (20%)
Category D
18 443 (24%) 1,106 (60%) 292 (16%)
19 523 (91%) 10 (2%) 45 (8%)
20 177 (25%) 313 (44%) 228 (32%)
RAP: Relationship Amplitude – Pressure.
Eide and Sorteberg BioMedical Engineering OnLine 2013, 12:14 Page 10 of 12
http://www.biomedical-engineering-online.com/content/12/1/14further, we therefore determined the proportion of 4-min observations wherein the
RAP was ≥0.6 in one signal while <0.6 in another (above normal threshold level in
one sensor and below in the other). Doing so, we found this setting in >20% of scores
in 12/20 patients; moreover, it occurred with every type of sensor being used in the
study. This observation is important because in the clinical setting, surveillance of
patients is based on the actual monitoring values that are revealed to the observer
(physician or nurse).
Due to erroneous ICP scores being incorporated into the RAP scores, its usefulness
as a guide in the management of neurosurgical patients will be hampered. In contrast,
as the ICP wave amplitude does not become affected by baseline pressure changes,
the ICP wave amplitude is a robust parameter. Thus, in a recent study comparing the
ICP waveforms ICP wave amplitude, ICP wave slope, and RAP as measures of intra-
cranial compliance in head injury patients, the ICP wave amplitude showed best per-
formance [19].
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The ICP sensors referred to in this study have been widely used for years; they thus all
represent state-of-the art technology for ICP monitoring. While the Edward’s fluid sen-
sor is extensively used for monitoring of fluid-pressures in general, including arterial
blood pressure, intraventricular pressure and central venous pressure, dedicated ICP
sensors were represented by the solid Codman ICP sensor [24-28], the air-pouch
Spiegelberg ICP sensor [29,30], and the fibreoptic Camino ICP sensor [31,32].Conclusions
Simultaneous monitoring of the ICP-derived index RAP from two separate ICP sensors
reveals marked differences in the index values. The differences in RAP may be
explained by erroneous scoring of the ICP level. This will hamper the usefulness of
RAP as a guide in the management of neurosurgical patients.
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